Education
About Us
Working with TipRanks
Follow Us
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.02Last Year’s EPS
0.02Same Quarter Last Year
Strong Buy
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: 15.76%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Positive
The earnings call presented a generally positive outlook with strong revenue growth, improved EBITDA, increased guidance, and progress in transitioning to a subscription-based model. Despite some challenges, such as a slight decrease in gross margin and a decrease in net revenue retention rate, the company demonstrated significant improvement in financial metrics and operational execution, positioning it well for future growth.Company Guidance
In the OptimizeRx First Quarter Fiscal 2025 earnings call, CEO Steve Silvestro reported strong financial performance, with Q1 revenues rising 11% year-over-year to $21.9 million and adjusted EBITDA improving to $1.5 million from a $0.3 million loss in the previous year. The company increased its full-year guidance, projecting revenues between $101 million and $106 million and adjusted EBITDA between $13 million and $15 million. The contracted revenue as of the end of Q1 exceeded $70 million, indicating over 80% visibility for the full year. The company's focus on transitioning to a subscription-based model showed early success, with over 5% of projected annual revenue converted to subscription contracts. Gross margins for the quarter were at 60.9%, slightly down from the previous year's 62%, influenced by an increase in DTC-related managed service revenue. OptimizeRx also reported a net revenue retention rate of 114% and average revenue per top 20 pharmaceutical manufacturer at approximately $3 million. The call highlighted the company's strategic initiatives, including leveraging a large point-of-care network and advancing a data-driven omnichannel technology platform to enhance customer engagement and improve patient outcomes.Revenue Increase and Improved EBITDA
First quarter 2025 revenues increased 11% year-over-year to $21.9 million, with adjusted EBITDA coming in at $1.5 million, an improvement of nearly $2 million year-over-year.
Strong Contracted Revenue Growth
Contracted revenue increased more than 20% year-over-year, positioning the company favorably for the rest of the year.
Increased Guidance for 2025
The company increased its guidance for the year, expecting revenue between $101 million and $106 million, with adjusted EBITDA between $13 million and $15 million.
Progress in Subscription-Based Model
Over 5% of projected annual revenue for 2025 has been converted to subscription contracts, indicating early momentum in transitioning to a subscription-based model.
Significant Improvement in Net Loss
Net loss for the first quarter of 2025 was $2.2 million, a substantial improvement from a net loss of $6.9 million in the same period of 2024.
Strong Operating Cash Flow
Operating cash flow came in at $3.9 million for the first quarter, with a cash balance of $16.6 million at the end of the quarter.
Decrease in Operating Expenses
Operating expenses for the quarter ended March 31, 2025, decreased by $1.8 million year-over-year.
---
OPRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OPRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $9.20 | $11.01 | +19.67% |
Mar 12, 2025 | $4.14 | $6.28 | +51.69% |
Nov 13, 2024 | $6.15 | $4.06 | -33.98% |
Aug 08, 2024 | $8.85 | $8.38 | -5.31% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does OptimizeRx Corporation (OPRX) report earnings?
OptimizeRx Corporation (OPRX) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is OptimizeRx Corporation (OPRX) earnings time?
OptimizeRx Corporation (OPRX) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OPRX EPS forecast?
OPRX EPS forecast for the fiscal quarter 2025 (Q2) is 0.02.
---